Friedman Eric J 4

What Happened

• Eric J. Friedman, a director of Integrated Biopharma Inc. (INBP), received a grant of 50,000 derivative shares (reported as an acquisition at $0.00) on 2026-06-24. The Form 4 classifies the transaction as an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-24; Form 4 filed: 2026-06-25 (filed the next day, appears timely).
• Reported consideration: $0.00 (no cash paid per the filing).
• Vesting schedule (footnote): vests in four equal installments of 12,500 on 9/30/2026, 12/31/2026, 3/31/2027 and 6/30/2027.
• Shares owned after the transaction: not specified in the provided filing details.
• Transaction type code: A (award/grant); derivative securities reported.

Context

• This is a compensation award (derivative grant) with a defined vesting schedule; it is not an exercise or an immediate stock purchase/sale. Such grants are common for director compensation and do not necessarily indicate near-term trading intent. The filing shows no immediate sale or cashless exercise tied to this grant.